1. Huang S, Li Z, Gao Z, Wang S, Sun J, Wu H, Liu J, Tang PM, Chen R, Qiao G. Effect of immunochemotherapy infusion timing, sequence, and interval on prognosis of advanced esophageal cancer: A retrospective cohort study. Int J Surg. 2024 Sep 6;111(1):1596–600. doi: 10.1097/JS9.0000000000002085. （中科院分区：1区，JCR分区：Q1，影响因子：12.5，作者排序：通讯作者，发表日期：2025-9-6）（南方医科大学珠江医院胸外科）
2. Junhan Wu, Weitao Zhuang, Rixin Chen, Haijie Xu, Zijie Li, Zihua Lan, Xin Xia, Zhe He, Shaopeng Li, Cheng Deng, Wei Xu, Qiuling Shi, Yong Tang, Guibin Qiao. Impact of surgery versus follow-up on psychological distress in patients with indeterminate pulmonary nodules: A prospective observational study. Qual Life Res. 2025 Jan 15. doi: 10.1007/s11136-024-03876-w. Epub ahead of print. PMID: 39812961. （中科院分区：2区，JCR分区：Q1，影响因子：3.3，作者排序：通讯作者，发表日期：2025-1-15）（南方医科大学珠江医院胸外科）
3. Zijie Li, Shujie Huang, Rixin Chen, Zhen Gao, Junhan Wu, Yizhang Chen, Weifeng Zhong, Sichao Wang, Guibin Qiao#. Association Between Treatment-Related Adverse Event Trajectory and Prognosis in Esophageal Cancer Receiving Neoadjuvant Immunochemotherapy.Annals of Surgical Oncology. 2024 Dec 27. （中科院分区：2区，JCR分区：Q1，影响因子：3.4，作者排序：通讯作者，发表日期：2024-12-27）（南方医科大学珠江医院胸外科）
4. Yizhang Chen, Shujie Huang, Rixin Chen, Zihua Lan, Zhen Gao, Zijie Li, Sichao Wang, Yong Tang, Guibin Qiao. Predicting prognosis of locally advanced esophageal squamous cell carcinoma through early changes in neutrophil-to-lymphocyte ratio following neoadjuvant immunochemotherapy. J Thorac Dis. 2024 Dec 31;16(12):8230-8239. doi: 10.21037/jtd-24-1115. （中科院分区：3区，JCR分区：Q3，影响因子：2.04，作者排序：通讯作者，发表日期：2024-12-31）（南方医科大学珠江医院胸外科）
5. Hansheng Wu, Junhan Wu, Xi Chen, Zihua Lan, Qibin Chen, Liangli Hong, Jinhai Yan, Shujie Huang, Jianrong Chen, Xirui Lin, Yong Tang, Haijie Xu, Guibin Qiao#. Sublobectomy and lymph node sampling are adequate for patients with invasive lung adenocarcinoma presenting as pure ground glass nodules. Clin Respir J. 2024 May;18(5):e13766. doi: 10.1111/crj.13766. （中科院分区：4区，JCR分区：Q3，影响因子：1.9，作者排序：通讯作者，发表日期：2024-5）（南方医科大学广东省人民医院胸外科）
6. Xuefeng Sun, Zihua Lan, Qiuling Shi, Hansheng Wu, Guojie Lu, Yuan Qiu, Yong Tang, Guibin Qiao#. Persistent cough after pulmonary resection: Minor issue, major hurdle. Heliyon. 2024 May 18;10(10):e31338. doi: 10.1016/j.heliyon.2024.e31338. （中科院分区：3区，JCR分区：Q1，影响因子：3.4，作者排序：通讯作者，发表日期：2024-5-18）（南方医科大学广东省人民医院胸外科）
7. Wei Dai, Yaqin Wang, Jia Liao, Xing Wei, Zhen Dai, Wei Xu, Yangjun Liu, Xin Shelley Wang, Cecilia Pompili, Hongfan Yu, Yang Pu, Yuqian Zhao, Bangrong Cao, Qifeng Wang, Wenhong Feng, Yuanqiang Zhang, Fang Liu, Yuanle Deng, Jin Zhou, Juan Li, Shaohua Xie, Run Xiang, Xiang Wang, Bo Tian, Xiaozun Yang, Bin Hu, Xiaoqin Liu, Tianpeng Xie, Xiaojun Yang, Xiang Zhuang, Guibin Qiao#, Qiang Li#, Qiuling Shi#. Electronic Patient-Reported Outcome-Based Symptom Management Versus Usual Care After Lung Cancer Surgery: Long-Term Results of a Multicenter, Randomized, Controlled Trial. J Clin Oncol. 2024 Jun 20;42(18):2126-2131. doi: 10.1200/JCO.23.01854. （中科院分区：1区，JCR分区：Q1，影响因子：42.1，作者排序：共同通讯作者，发表日期：2024-6-20）（南方医科大学广东省人民医院胸外科）
8. Shujie Huang*, Sichao Wang*, Zhen Gao*, Zijie Li, Hansheng Wu, Wei Xu, Yong Tang, Zhe He, Junhui Fu, Guibin Qiao. Induction Immunochemotherapy Yields a Higher Conversion Rate and Better Overall Survival than Chemotherapy in Initially Unresectable Esophageal Squamous Cell Carcinoma. Ann Surg Oncol. 2024 May 25. doi: 10.1245/s10434-024-15458-8. Epub ahead of print. PMID: 38796589.（中科院分区：2区，JCR分区：Q1，影响因子：3.39，作者排序：通讯作者，发表日期：2024-4-27）（南方医科大学广东省人民医院胸外科）
9. Jiming Tang, Shujie Huang, Qibin Chen, Hansheng Wu, Guibin Qiao. Optimal extent of lymphadenectomy improves prognosis and guides adjuvant chemotherapy in esophageal cancer: A propensity scorematched analysis. World Journal of Gastrointestinal Surgery. 2024 June 27; 16(6):0-0. doi: 10.4240/wjgs.v16.i6.0000. （中科院分区：4区，JCR分区：Q4，影响因子：2.0，作者排序：通讯作者，发表日期：2024-6，被引次数：，他引次数：）（南方医科大学广东省人民医院胸外科）
10. Shujie Huang1#, Hongfan Yu2#, Zijie Li1#, Yong Tang1，Liling Luo3，Junhan Wu1, Xianglin Li1, Qiuling Shi2,4, Songxi Xie3, Guibin Qiao。Electronic patient-reported outcome-based surveillance system to evaluate safety and efficacy of preoperative immunochemotherapy with or without short-term chemoradiation in patients with esophageal squamous cell carcinoma (ePRO-PICCRT): protocol for a prospective, single-arm, phase II study。J Thorac Dis 2024 | https://dx.doi.org/10.21037/jtd-24-274（中科院分区：3区，JCR分区：Q3，影响因子：2.04，作者排序：大通讯作者）
11. Xuefeng Sun*, Zihua Lan*, Qiuling Shi, Hansheng Wu, Guojie Lu, Yuan Qiu, Yong Tang#, Guibin Qiao#. Persistent cough after pulmonary resection: Minor issue,majorhurdle.Heliyon.2024;10(10):e31338.doi:10.1016/j.heliyon.2024.e31338（中科院分区：3区，JCR分区：Q2，影响因子：4.0，作者排序：大通讯作者，发表日期：2024-5-30）（南方医科大学广东省人民医院胸外科）
12. Junhan Wu, Xin Xia, Longlong Gong, Shujie Huang, Hongbo Zheng, Guibin
Qiao & Yong Tang .Neoadjuvant chemoimmunotherapy for small cell carcinoma of the esophagus: Clinical efficacy and biomarker exploration.Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2024.2370085
13. Zihua Lan*, Cheng Zeng*, Zijie Li*, Xin Xia, Aotian Mo, Xianglin Li, Xiaosong Ben, Haiyu Zhou, Cheng Deng, Rixin Chen, Qiuling Shi, Yong Tang#, Guibin Qiao#. Early patient-reported outcomes after robotic-assisted versus video-assisted thoracoscopic lobectomy. Thorac Cancer. Published online May 30, 2024. doi:10.1111/1759-7714.15379（中科院分区：3区，JCR分区：Q3，影响因子：2.90，作者排序：大通讯作者，发表日期：2024-5-30，被引次数：，他引次数：）（南方医科大学广东省人民医院胸外科）
14. Ri-Xin Chen*, Shui-Dan Xu*, Min-Hua Deng*, Shi-Hui Hao*, Jie-Wei Chen, XiaoDan Ma, Wei-Tao Zhuang, Jing-Hua Cao, Yong-Rui Lv, Jin-Long Lin, Si-Yu Li, GuiBin Qiao#, Dan Xie#, Feng-Wei Wang#. Mex-3 RNA binding family member A (MEX3A) /circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy. Signal Transduction and Targeted Therapy. 2024 Apr 2;9(1):80.doi: 10.1038/s41392-024-01787-3.（中科院分区：1区，JCR分区：Q1，影响因子：39.3，作者排序：共同通讯作者，发表日期：2024-4-2，被引次数：，他引次数：）（南方医科大学广东省人民医院胸外科）
15. Min Ma*, Liang Li*,#, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao, Qingyun Chen, Guibin Qiao#, Zhe-Xiong Lian#. Lymphatic endothelial cell-mediated accumulation of CD177+Treg cells suppresses antitumor immunity in human esophageal squamous cell carcinoma. Oncoimmunology (IF:7.2). 2024 Mar 20;13(1):2327692. doi: 10.1080/2162402X.2024.2327692.（中科院分区：2区，JCR分区：Q1，影响因子：7.20，作者排序：共同通讯作者，发表日期：2024-3-20，被引次数：，他引次数：）（南方医科大学广东省人民医院胸外科）
16. Gao Z, Huang S, Wang S, Tang D, Xu W, Zeng R, Qiao G* (通讯作者). Efficacy and safety of immunochemotherapy, immunotherapy, chemotherapy, and targeted therapy as first-line treatment for advanced and metastatic esophageal cancer: a systematic review and network meta-analysis. Lancet Reg Health West Pac (IF:7.1). 2023 Jul 6;38:100841. doi: 10.1016/j.lanwpc.2023.100841.
17. Liu J, Chen H, Qiao G# (共同第一) Zhang JT, Zhang S, Zhu C, Chen Y, Tang J, Li W, Wang S, Tian H, Chen Z, Ma D, Tian J, Wu YL. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma. Cancer Immunol Immunother (IF:5.8). 2023 Apr;72(4):881-893. doi: 10.1007/s00262-022-03288-0. Epub 2022 Sep 19.
18. Huang S, Wu J, Li S, Li X, Zeng R, Tang Y, Tang J, Ben X, Zhang D, Xie L, Zhou H, Chen G, Wang S, Gao Z, Wu H, Chen R, Xu F, Qiao G* (通讯作者). Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer. Lung Cancer (IF=5.7). 2023 Dec;186:107401. doi: 10.1016/j.lungcan.2023.107401. Epub 2023 Oct 12.
19. Zhang Y, Zhang Y, He P, Ge F, Huo Z, Qiao G* (通讯作者). The genetic liability to rheumatoid arthritis may decrease hepatocellular carcinoma risk in East Asian population: a Mendelian randomization study. Arthritis Res Ther (IF=4.9) 2023 Mar 27;25(1):49. doi: 10.1186/s13075-023-03029-3.
20. Liu S, Li S, Tang Y, Chen R, Qiao G* (通讯作者). Minimally invasive surgery vs. open thoracotomy for non-small-cell lung cancer with N2 disease: a systematic review and meta-analysis. Front Med (Lausanne) (IF=3.9). 2023 May 31;10:1152421. doi: 10.3389/fmed.2023.1152421.
21. Huang S, Tang Y, Wu H, Shi Q, Tang J, Ben X, Zhang D, Xie L, Zhou H, Chen G, Wang S, Gao Z, Xie Z, Chen R, Qiao G* (通讯作者). Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy. Ann Surg Oncol (IF=3.7). 2023 Aug;30(8):5171-5181. doi: 10.1245/s10434-023-13467-7. Epub 2023 Apr 24.
22. Wu J, Zhuang W, Xu H, Tang Y, Li S, Xu W, Sun X, Li X, Qiao G* (通讯作者). Investigation on sleep quality and psychological distress in patients with pulmonary nodules. BMC Psychol (IF=3.6). 2023 Sep 1;11(1):258. doi: 10.1186/s40359-023-01274-4.
23. Liu JH, Lin JZ, Qiu Q, Zhu C, Li W, Li Q, Huang Z, Xia X, Qiao G* (共同通讯), Tang J. COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy. Thorac Cancer (IF=2.9). 2023 May;14(14):1294-1305. doi: 10.1111/1759-7714.14873. Epub 2023 Apr 2.
24. Q. Gao*, Y. P. Lin *, B. S. Li *, G. Q. Wang , L. Q. Dong, B. Y. Shen , W. H. Lou , W. C. Wu , D. Ge , Q. L. Zhu , Y. Xu , J. M. Xu , W. J. Chang , P. Lan , P. H. Zhou , M. J. He, G. B. Qiao, S. K. Chuai , R. Y. Zang, T. Y. Shi, L. J. Tan , J. Yin , Q. Zeng, X. F. Su, Z. D. Wang, X. Q. Zhao, W. Q. Nian, S. Zhang , J. Zhou, S. L. Cai , Z. H. Zhang & J. Fan#. Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies. Annals of Oncology. 2023;34(5):486-495. doi:10.1016/j.annonc.2023.02.010（中科院分区：1区，JCR分区：Q1，影响因子：51.769，作者排序：第17，发表日期：2023-05-28，被引次数：0，他引次数：0）（广东省人民医院胸外科）
25. Xiao J, Zhang L, Yi H, Zou L, Mo J, Xue F, Zheng J, Huang Y, Lu H, Wu H, Xue P, Zhang X, He L, Li Z, Pang S, Qiao G* (通讯作者), Duan Q, Zhu F. Inhibiting ALK-TOPK signaling pathway promotes cell apoptosis of ALK-positive NSCLC. Cell Death Dis (IF=9.0). 2022 Sep 27;13(9):828. doi: 10.1038/s41419-022-05260-3.
26. Huang S, Wu H, Cheng C, Zhou M, Xu E, Lin W, Wang G, Tang J, Ben X, Zhang D, Xie L, Zhou H, Chen G, Zhuang W, Tang Y, Xu F, Du Z, Xie Z, Wang F, He Z, Zhang H, Sun X, Li Z, Sun T, Liu J, Yang S, Xie S, Fu J, Qiao G* (通讯作者). Conversion Surgery Following Immunochemotherapy in Initially Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma-A Real-World Multicenter Study (RICE-Retro). Front Immunol (IF=7.3). 2022 Jul 13;13:935374. doi: 10.3389/fimmu.2022.935374.
27. Sun Xuefeng, Lan Zihua, Li Shaopeng, Huang Shujie, Zeng Cheng, Wu Junhan, Chen Qibin, Chen Yizhang, Chen Ziguo, Tang Yong, Qiao Guibin.Trajectories and risk factors of persistent cough after pulmonary resection: A prospective two-center study. Thorac Cancer. 2023 Dec;14(36):3503-3510. doi: 10.1111/1759-7714.15147. （中科院分区：3区，JCR分区：Q3，影响因子：2.9，作者排序：共同通讯作者，发表日期：2023-12，被引次数：，他引次数：）（南方医科大学广东省人民医院胸外科）
28. Ding Y, Zhang J, Zhuang W, Gao Z, Kuang K, Tian D, Deng C, Wu H, Chen R, Lu G, Chen G, Mendogni P, Migliore M, Kang MW, Kanzaki R, Tang Y, Yang J, Shi Q, Qiao G* (通讯作者). Improving the efficiency of identifying malignant pulmonary nodules before surgery via a combination of artificial intelligence CT image recognition and serum autoantibodies. Eur Radiol (IF=5.9). 2023 May;33(5):3092-3102. doi: 10.1007/s00330-022-09317-x. Epub 2022 Dec 8.
29. Jingyu Zhang*, Sichao Wang*, Zihao Zhou , Cheng Lei , Hongfan Yu , Cheng Zeng , Xin Xia , Guibing Qiao#, Qiuling Shi#. Unpleasant symptoms of immunotherapy for people with lung cancer: A mixed-method study. International Journal of Nursing Studies. 2023 Mar;139:104430. doi: 10.1016/j.ijnurstu.2022.104430. Epub 2022 Dec 15. （中科院分区：1区，JCR分区：Q1，影响因子：7.57，作者排序：共同通讯作者，发表日期：2022-12-15，被引次数：，他引次数：）（广东省人民医院胸外科、南方医科大学第二临床医学院）
30. Sun T, Huang S, Jiang Y, Yuan H, Wu J, Liu C, Zhang X, Tang Y, Ben X, Tang J, Zhou H, Zhang D, Xie L, Chen G, Zhao Y, Wang S, Xu H, Qiao G* (通讯作者). Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy. Front Bioeng Biotechnol (IF=5.7) 2022 Oct 6;10:1010672. doi: 10.3389/fbioe.2022.1010672.
31. Chen X, Xian B, Wei J, Chen Y, Yang D, Lai X, Liu L, Wu Y, Lin X, Deng Y, Zhang H, Liu W, Qiao G* (通讯作者) Li Z. Predictive value of the presence of Prevotella and the ratio of Porphyromonas gingivalis to Prevotella in saliva for esophageal squamous cell carcinoma. Front Cell Infect Microbiol (IF=5.7). 2022 Oct 13;12:997333. doi: 10.3389/fcimb.2022.997333.
32. Huang SJ, Tian D, Wang SC, Zeng RJ, Dong YJ, Hong LL, Wu HS, Xu FP, Zhang DK, Xie L, Zhou HY, Tang JM, Ben XS, Chen G, Chen RX, Tang Y, Qiao GB* (通讯作者) Pathological Responses of the Primary Tumor and Locoregional Lymph Nodes After Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Cancer. World J Oncol (IF=5.2). 2022 Aug;13(4):195-204. doi: 10.14740/wjon1489. Epub 2022 Aug 23.
33. Zhuang W, Wu H, Chen R, Ben X, Huang S, Zhou Z, Wu J, Tang Y, Qiao G* (通讯作者). The staging performance of a modified tumor-node-metastasis staging system incorporated with lymphovascular invasion in patients with esophageal squamous cell carcinoma. Front Oncol (IF=4.7). 2022 Oct 13;12:1018827. doi: 10.3389/fonc.2022.1018827.
34. Zhuang Weitao*, Ben Xiaosong*, Zhou Zihao., Ding Yu., Tang Yong., Huang Shujie., Deng Cheng., Liao Yuchen., Zhou Qiaoxia., Zhao Jing., Wang Guoqiang., Xu Yu., Wen Xiaofang., Zhang Yuzi., Cai Shangli., Chen Rixin., Qiao Guibin.(2021). Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma. Journal of Oncology. 2021 Dec 22;2021:3726058. doi: 10.1155/2021/3726058. PMID: 34976055;（中科院分区：3区，JCR分区：Q2，影响因子：4.501，作者排序：通讯作者，发表日期：2021-12-22，被引次数：，他引次数：）（广东省人民医院胸外科）
35. Wu H, Xu H, Huang S, Tang Y, Tang J, Zhou H, Xie L, Qiao G* (通讯作者). m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma. Front Oncol (IF=4.7). 2022 Sep 28;12:989817. doi: 10.3389/fonc.2022.989817.
36. Dongkun Zhang#, Weitao Zhuang#, Zihua Lan#, Shujie Huang, Zhen Gao, Qibin Chen, Xiaosong Ben, Jiming Tang, Haiyu Zhou, Liang Xie, Guibin Qiao. Long-term follow-up in quality of life before and after endoscopic thoracic sympathicotomy in 367 patients with palmar hyperhidrosis. Annals of Palliative Medicine. 2022;11(6):1961-1968. doi:10.21037/apm-21-2860 PMID: 35016525 （中科院分区：4区，JCR分区：Q4，影响因子：1.93，作者排序：通讯作者，发表日期：2022-1-10，被引次数：，他引次数：）（广东省人民医院胸外科）
37. Ben X, Tian D, Zhuang W, Chen R, Wang S, Zhou Z, Deng C, Shi R, Liu S, Zhang D, Tang J, Xie L, Zhou H, Zhang Z, Li M, Zhang X, Qiao G* (通讯作者). Accuracy of next-generation sequencing for molecular profiling of small specimen of lung cancer: a prospective pilot study of side-by-side comparison. Diagn Pathol (IF=2.6). 2022 Oct 12;17(1):78. doi: 10.1186/s13000-022-01255-y.
38. Zhuang W, Wu J, Xu H, Deng C, Li S, Tian D, Ben X, Xu W, Tang Y, Qiao G* (通讯作者). Exploring the psychological profile: a cross-sectional study of 1,185 patients with pulmonary nodules in an outpatient clinic. J Thorac Dis (IF=2.5). 2022 Dec;14(12):4699-4712. doi: 10.21037/jtd-22-847.
39. Zhuang W, Tang Y, Xu W, Huang S, Deng C, Chen R, Zhang D, Zeng C, Tian D, Ben X, Lan Z, Wu H, Gao Z, Wang M, Chen Y, Shi Q, Qiao G* (通讯作者). Should psychological distress be listed as a surgical indication for indeterminate pulmonary nodules: protocol for a prospective cohort study in real-world settings. J Thorac Dis (IF=2.5). 2022 Mar;14(3):769-778. doi: 10.21037/jtd-21-1423.
40. Zhuang W, Wei P, Qiao G* (通讯作者). Quadriplegia After Removal of an Accidentally Ingested Chicken Bone. Gastroenterology (IF=29.4). 2022 Feb;162(2):e11-e13. doi: 10.1053/j.gastro.2021.06.018. Epub 2021 Jun 17.
41. Wu H, Zhuang W, Huang S, Guan X, Zheng Y, Xie Z, Chen G, Tang J, Zhou H, Xie L, Ben X, Zhou Z, Li Z, Chen R, Qiao G* (通讯作者). Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma. Front Oncol (IF=4.7). 2021 May 25;11:619556. doi: 10.3389/fonc.2021.619556.
42. Zhuang W, Zhang C, Tang Y, Tian D, Lan Z, Zeng C, Qiao G* (通讯作者). Clinical and Pathologic Complete Response to Gefitinib in a Patient with SqCLC Harboring EGFR p.E746_S752delinsV Mutation. Onco Targets Ther (IF=4.0). 2021 Sep 15;14:4805-4808. doi: 10.2147/OTT.S328839.
43. Huang S, Zhuang W, Wang D, Zha L, Xu X, Li X, Shi Q, Wang XS, Qiao G* (通讯作者). Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study. Med Sci Monit (IF=3.1). 2021 Apr 15;27:e930447. doi: 10.12659/MSM.930447.
44. Wu H, Huang S, Zhuang W, Qiao G* (通讯作者). Prognostic significance of eight immune-related genes on survival in patients with lung squamous cell carcinoma. Biomark Med (IF=2.2). 2021 Mar;15(4):295-306. doi: 10.2217/bmm-2020-0483. Epub 2021 Feb 16.
45. Qiao G# (第一作者), Zhuang W, Dong B, Li C, Xu J, Wang G, Xie L, Zhou Z, Tian D, Chen G, Tang J, Zhou H, Zhang D, Shi R, Chen R, Nian W, Zhang Y, Zhao J, Wen X, Xu Y, Li B, Zhang Z, Cai S, Ben X, Qi Y. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study. BMC Med (IF=9.3). 2021 Oct 13;19(1):243. doi: 10.1186/s12916-021-02109-y.
46. Zhuang W, Zhang J, Wei P, Lan Z, Chen R, Zeng C, Shi Q, Qiao G *(通讯作者). Misconception contributed to COVID-19 vaccine hesitancy in patients with lung cancer or ground-glass opacity: a cross-sectional study of 324 Chinese patients. Hum Vaccin Immunother (IF=4.8). 2021 Dec 2;17(12):5016-5023. doi: 10.1080/21645515.2021.1992212. Epub 2021 Oct 29.
47. Zhuang W, Huang S, Wang D, Zha L, Xu W, Qiao G* (通讯作者). Risk factors associated with prolonged viral clearance in patients with a refractory course of COVID-19: a retrospective study. PeerJ (IF=2.7). 2021 Nov 23;9:e12535. doi: 10.7717/peerj.12535.
48. Zhuang W, Qiao G* (通讯作者). Pregnancy-associated lung cancer: a clinical and scientific challenge more than treatment dilemma. J Thorac Dis (IF=2.5). 2021 Sep;13(9):5572-5574. doi: 10.21037/jtd-21-1220.
49. Sichao Wang*, Zihao Zhou*, Dan Tian*, Shujie Huang, Ce Wang, Zhen Gao, Xiaosong Ben, Jiming Tang, Liang Xie, Haiyu Zhou, Dongkun Zhang, Ruiqing Shi, Cheng Deng, Weitao Zhuang, Yu Ding, Guibin Qiao#. A validated nomogram integrating hematological indicators to predict response to neoadjuvant therapy in esophageal squamous cell carcinoma patients. Annals of Translational Medicine. 2021 Apr;9(8):703. doi: 10.21037/atm-21-1628. PMID: 33987401; PMCID: PMC8106100.（中科院分区：4区，JCR分区：Q3，影响因子：3.616，作者排序：通讯作者，发表日期：2021-04，被引次数：3，他引次数：3）（广东省人民医院胸外科）
50. Zhuang W, Wu H, Liu H, Huang S, Wu Y, Deng C, Tian D, Zhou Z, Shi R, Chen G, Piessen G, Khaitan PG, Koyanagi K, Ozawa S, Qiao G* (通讯作者). Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage. J Gastrointest Oncol (IF=2.1). 2021 Apr;12(2):433-445. doi: 10.21037/jgo-21-133.
51. Shen J, Zhuang W, Xu C, Jin K, Chen B, Tian D, Hiley C, Onishi H, Zhu C, Qiao G* (通讯作者). Surgery or Non-surgical Treatment of ≤8 mm Non-small Cell Lung Cancer: A Population-Based Study. Front Surg (IF=1.8). 2021 May 26;8:632561. doi: 10.3389/fsurg.2021.632561
52. Dan Tian* , Xiaosong Ben* , Sichao Wang*, Weitao Zhuang, Jiming Tang, Liang Xie, Haiyu Zhou, Dongkun Zhang, Zihao Zhou, Ruiqing Shi, Cheng Deng, Yu Ding, Xuanye Zhang#, Guibin Qiao#. Surgical resection of primary tumors improved the prognosis of patients with bone metastasis of non-small cell lung cancer: a population-based and propensity score-matched study. Annals of Translational Medicine. 2021 May;9(9):775. doi: 10.21037/atm-21-540. PMID: 34268388; PMCID: PMC8246174.（中科院分区：4区，JCR分区：Q3，影响因子：3.616，作者排序：第一通讯作者，发表日期：2021-05，被引次数：2，他引次数：2）（广东省人民医院胸外科）
53. Gao Zhen*, Huang Shujie*, Tang Yong, Wang Sichao, Zhuang Weitao, Ding Yu, Wu Hansheng, Tang Jiming, Zhang Dongkun, Zhou Haiyu, Ben Xiaosong, Xie Liang, Chen Gang, Qiao Guibin#. Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure. Annals of translational medicine, 2021 Aug;9(16):1335. doi: 10.21037/atm-21-3822. （中科院分区：4区，JCR分区：Q3，影响因子：3.616，作者排序：第一通讯作者，发表日期：2021-8-9，被引次数：2，他引次数：1） （广东省人民医院胸外科）
54. Tang Y, Li Y, Zhang L, Tong G, Ou Z, Wang Z, Zhang H, Qiao G* (通讯作者). Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report. Thorac Cancer (IF=2.9). 2020 Apr;11(4):1094-1098. doi: 10.1111/1759-7714.13361.
55. Tang Y, Liu X, Ou Z, He Z, Zhu Q, Wang Y, Yang M, Ye J, Han-Zhang H, Qiao G* (通讯作者). Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity. Oncol Lett (IF=2.9). 2019 Aug;18(2):2118-2124. doi: 10.3892/ol.2019.10490.
56. Tang Y, Ou Z, Yao Z, Qiao G* (通讯作者). A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma. Medicine (Baltimore) (IF=1.6). 2019 Oct;98(40):e17164. doi: 10.1097/MD.0000000000017164.
57. Shi Ruiqing*, Xie Liang*, Chen Gang, Zeng Qi, Mo Xuming, Tang Jiming, Zhou Haiyu, Zhang Dongkun, Ye Xiong, Zhou Zihao, Tian Dan, Deng Cheng, Ben Xiaosong#, Qiao Guibin#. Surgical management of pectus excavatum in China: results of a survey amongst members of the Chinese Association of Thoracic Surgeons. Annals of Translational Medicine. 2019 May;7(9):202. doi: 10.21037/atm.2019.05.03. （中科院分区：4区，JCR分区：Q3，影响因子：3.616，作者排序：第一通讯作者，发表日期：2019-5，被引次数：，他引次数：）（广东省人民医院胸外科）
58. Zhou ZH, Chen G, Deng C, Tang JM, Xie L, Zhou HY, Ye X, Zhang DK, Shi RQ, Tian D, Qiao GB*(通讯作者), Ben XS. TCF19 contributes to cell proliferation of non-small cell lung cancer by inhibiting FOXO1. Cell Biol Int (IF=3.9). 2019 Dec;43(12):1416-1424. doi: 10.1002/cbin.11189. Epub 2019 Jul 11. Erratum in: Cell Biol Int. 2022 Jun;46(6):990-991
59. Zhou J, Xiao H, Yang X, Tian H, Xu Z, Zhong Y, Ma L, Zhang W, Qiao G**(通讯作者), Liang J. Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma. Sci Rep (IF=4.6). 2018 Jan 8;8(1):37. doi: 10.1038/s41598-017-18280-3.
60. Tang Y, Qiao G*(通讯作者), Xu E, Xuan Y, Liao M, Yin G. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer. Onco Targets Ther (IF=4.0). 2017 Sep 12;10:4527-4534. doi: 10.2147/OTT.S142149.
61. Tang Y, Ou ZA, Liao M, Xuan Y, Su K, Xu EW, Xiao H, Peng X, Zhang Z, Liu Y, Qiao G* (通讯作者). Subcostal thoracoscopic extended thymectomy for patients with myasthenia gravis. J Thorac Dis (IF=2.5). 2016 Mar;8(3):499-504. doi: 10.21037/jtd.2016.02.77. 72.
62. Zhu Q, Xiao H, Xu E, Liao M, Tang Y, Xuan Y, Su K, He Z, Peng X, Zhang Z, Liu Y, Qiao G* (通讯作者). From open to single port video-assisted thoracoscopic lobectomy: a stepwise and return progression of the experience from Department of Thoracic Surgery, General Hospital of Guangzhou Military Command of P.L.A. J Thorac Dis (IF=2.5). 2015 Jul;7(7):1252-63. doi: 10.3978/j.issn.2072-1439.2015.06.12. 67.
63. Tang Y, He Z, Zhu Q, Qiao G* (通讯作者). The 2011 IASLC/ATS/ERS pulmonary adenocarcinoma classification: a landmark in personalized medicine for lung cancer management. J Thorac Dis (IF=2.5). 2014 Oct;6(Suppl 5):S589-96. doi: 10.3978/j.issn.2072-1439.2014.09.15.74.
64. Qiao GB# (第一作者), Fang Y, Zeng WS, Peng LJ, Huang WJ. Images for diagnosis. An unusual case of Carney triad with high level catecholamine-secreting but no existence of extra-adrenal paraganglioma. Chin Med J (Engl) (IF=6.1). 2010 Feb 20;123(4):510-2.
65. Qiao GB# (第一作者), Zeng WS, Peng LJ, Zhong WZ, Fang Y, Huang WJ, Wu YL. Multiple pulmonary chondromas in a young female patient: a component of Carney triad. J Thorac Oncol (IF=20.4). 2009 Jun;4(6):751-2. doi: 10.1097/JTO.0b013e3181a52a99.
66. 食管癌及食管胃交界部癌外科持续质量改进目标中国专家共识（2024版）
67. 中国食管癌及食管胃交界部癌围手术期并发症定义及分级专家共识（2023版）
68. 何哲，朱启航，李祥麟，汤德钊，吴俊翰，陈奕璋，陈启彬，张其鹏，徐恩五，肖海平，唐勇，乔贵宾* (通讯作者), 新冠病毒感染后肺癌手术时机及安全性的多中心回顾性研究, 中国胸心血管外科临床杂志(北大核心) , 2023. doi:10.7507/1007-4848.20230301
69. 吴俊翰，庄伟涛，许海杰，唐勇，邓澄，吴汉生，乔贵宾* (通讯作者). 肺结节患者群体焦虑抑郁情绪及其影响因素的横断面研究. 中国胸心血管外科临床杂志(北大核心), 2022. doi: 10.7507/1007-4848.202202040
70. 许海杰，庄伟涛，王琪，吴俊翰，吴汉生，陈雅丽，唐勇，乔贵宾(中文核心). 肺结节患者呼吸系统症状分布及其影响因素的横断面研究. 中国胸心血管外科临床杂志(北大核心), 2022. doi: 10.7507/1007-4848.202206045
71. 乔贵宾# (第一作者),傅睿.纳武利尤单抗联合化疗在非小细胞肺癌新辅助治疗中的应用[J].循证医学,2022,22(01):26-29.
72. 吴汉生，黄树杰，乔贵宾* (通讯作者), m6A甲基化修饰与肺癌, 国际肿瘤学，2021，48 (4)：35-40
73. 高枕, 乔贵宾* (通讯作者). 影像组学在肺癌诊疗领域的研究及应用进展. 中华生物医学工程杂志, 2021,27(1) : 107-112. DOI: 10.3760/cma.j.cn115668-20200819-00215.
74. 庄伟涛，乔贵宾* (通讯作者). 基于表观遗传标志的液体活检在实体瘤诊疗中的研究与应用. 国际肿瘤学杂志(中文核心), 2021,48(6):358-361. DOI: 10.3760/cma.j.cn371439-20200918-00068
75. 庄伟涛，高枕，曾伟生，徐恩五，唐勇，肖海平，陈刚，贲晓松，乔贵宾* (通讯作者) . 胸部巨大肿瘤外科治疗的基本原则与质量控制，中国胸心血管外科临床杂志(北大核心), 2020, 27(9) 996-1000. doi: 10.7507/1007-4848.202004071
76. 乔贵宾#(第一作者)，莫绪明，曾骐。漏斗胸外科治疗中国专家共识。中华小儿外科杂志 (中文核心)，2020,41(1):7-12
77. 丁宇，乔贵宾* (通讯作者),液体活检在肺癌早期诊断中的应用，国际肿瘤学杂志 (中文核心)，2019,46(9):548-552.
78. 唐勇，乔贵宾* (通讯作者), EGFR敏感突变II~IIIA期非小细胞肺癌治疗的研究进展。中国肿瘤临床杂志(中文核心), 2019,46(14):707-711
79. 唐勇，艺文，肖海平，廖明，区柱安，朱启航，何哲，刘岩，乔贵宾* (通讯作者),经肋缘下胸腔镜胸腺扩大切除术中不常规留置纵隔引流管的临床研究, 中国微创外科杂志 (中文核心), 2019,2:118-120.
80. 唐勇，区柱安，刘岩，肖海平，廖明，朱启航，何哲，徐恩五，苏凯，乔贵宾* (通讯作者), 加速康复外科在微创食管癌根治术中的应用价值, 中华消化外科杂志 (中文核心), 2019,18(6):570-574.
81. 王天佑,胸外科围手术期肺保护中国专家共识 (2019版)专家组,中国医学基金会胸外科专业委员会.胸外科围手术期肺保护中国专家共识(2019版).中国胸心血管外科临床杂志,2019,26(9):835-842. Doi：10.7507/1007-4848.201907056 被引30次 作为专家组成员
82. 乔贵宾#* (第一作者、通讯作者),陈刚. 创伤性肋骨骨折的处理:广东胸外科行业共识(2017年版)[J].中国胸心血管外科临床杂志 (中文核心),2018,25(5):362-367. Doi: 10.7507/1007-4848.201710008
83. 乔贵宾#* (第一作者、通讯作者),陈刚.自发性气胸的处理:广东胸外科行业共识(2016年版).中国胸心血管外科临床杂志 (中文核心),2017,24(1):6-15. DOI: 10.7507/1007-4848.201611046
84. 朱启航、肖海平、何哲、区柱安、乔贵宾* (通讯作者).3种电视胸腔镜下手术治疗非小细胞肺癌早期创伤反应的比较,实用医学杂志,
85. 徐恩五，朱启航，何哲，乔贵宾* (通讯作者), 呼出气一氧化氮检测在肺癌诊断中的应用, 广东医学, 2016 年 1 月，37 卷1 期
86. 徐恩五，李俊璞，曾茜，乔贵宾* (通讯作者)。一种不倒翁式胸腔闭式引流瓶的研制, 医疗卫生装备, 2015 年 6 月，36 卷6 期
87. 何哲、乔贵宾、查露露。华南地区国人肋骨骨折的流行病学调查。海南医学, 2015年4月，26卷7期
88. 何哲，乔贵宾，欧阳钧, 国人第3~7肋影像解剖学测量及其临床意义, 中国临床解剖学杂志, 2015 年，33 卷 1 期
89. 唐勇、徐恩五、廖明、彭丽君、肖海平、彭秀凡、刘岩、乔贵宾* (通讯作者), 电视胸腔镜手术与胸骨劈开扩大胸腺切除术治疗重症肌无力的临床对比研究, 中国微创外科杂志, 2014 年 12 月，14 卷12 期
90. 何哲、乔贵宾、徐恩五, 手术治疗重度肋骨骨折的疗效及经济学分析, 中华创伤杂志, 2014年 12月，30卷12期
91. 徐恩五、乔贵宾* (通讯作者),肺癌的微创外科治疗,中国微创外科杂志, 2012 年 8 月， 12 卷8 期
92. 彭丽君、曾伟生、乔贵宾、蒋仁超、庞大志、彭秀凡、吴一龙, 错配切割修复蛋白表达与非小细胞肺癌术后 辅助化疗效果的关系, 广东医学, 2010年 6月 ， 31卷11期
93. 乔贵宾#* (第一作者、通讯作者), Rad51在同源重组中作用及其与肿瘤关系的研究进展, 中华肿瘤防治杂志, 2010 年 2 月， 17 卷4 期
94. 乔贵宾# (第一作者), 曾伟生, 彭丽君, 吴一龙。非小细胞肺癌组织 Rad51 高表达及其临床意义的研究, 中华肿瘤防治杂志, 2009 年 7 月， 16 卷14 期
95. 乔贵宾# (第一作者)、曾伟生、彭丽君、蒋仁超、庞大志、彭秀凡、吴一龙, 同侧肺多结节非小细胞肺癌的外科治疗, 中华外科杂志, 2009年7月，47卷14期
96. 乔贵宾#* (第一作者、通讯作者), 胸部肿瘤诊疗中的伦理问题, 中国医学伦理学, 2009年 6月， 22卷3期
97. 乔贵宾# (第一作者)、曾伟生、彭丽君、蒋仁超、庞大志、彭秀凡、吴一龙, 伴有肺内转移细支气管肺泡癌的外科治疗, 中华肿瘤杂志, 2009年8月，31卷8期
98. 乔贵宾#* (第一作者、通讯作者), KRAS基因突变与肺腺癌对 Gefitinib 和 Erlotinib 原发耐药的关系, 循证医学, 2008 年 8 月 ，8 卷4 期